Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eldecalcitol combined with whey protein and exercise for sarcopenia
ChiCTR2400085142Phase 4Not yet recruiting
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- May 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of eldecalcitol in Sarcopenia (3 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoints: Muscle mass and Grip strength. Planned start May 2024; status: not yet recruiting.
02
Drugs
eldecalcitol
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on ChiCTR2400085142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085142.